| Francesco Bellini | |
|---|---|
Francesco Bellini (2006)
|
|
| Born | Ascoli Piceno, Italy, |
| Residence | came to Canada, Quebec, in 1967 |
| Fields | research scientist administrator entrepreneur business man |
| Notable awards | severals awards receive from 1987 to 2005 |
Francesco Bellini, CM, OQ is research scientist, administrator, entrepreneur and Quebecer business man born in Italy, Ascoli Piceno, in 1947.
He is a pioneer scientist-entrepreneur in the Canadian bio-pharmaceutical industry, he was co-founder of Biochem Pharma, as well as Chairman & Chief Executive Officer from 1986 to 2001. He has authored or co-authored more than twenty-five patents over his 20-year career as a research scientist.
Contents |
Born in 1947 in Ascoli Piceno, Italy, Dr. Bellini came to Canada in 1967. He received his Bachelor of Science degree from Loyola College (now Concordia University) in 1972 and his Doctorate in organic chemistry from University of New Brunswick in 1977. He is the author or co-author of some 25 patents and has published numerous articles and papers based on his research.
Dr. Francesco Bellini runs BELLUS Health, a company which develops new health products. BELLUS Health is engaged in pharmaceutical and nutraceutical activities. Dr. Bellini is also Chairman of Picchio International, Picchio Pharma, Prognomix and ViroChem Pharma – all companies involved in healthcare. He was also the Chairman, President, and CEO of Neurochem, which was developing Alzhemed, a compound for the treatment of Alzheimer's Disease that ultimately failed in late stage clinical trials. Prior to this, Dr. Bellini was Chairman and CEO of BioChem Pharma an innovative biopharmaceutical company focused on infectious diseases and cancer, which he co-founded in 1986. From 1968 to 1984, he had a fruitful career as a researcher at the Canadian subsidiary of a multinational pharmaceutical company. In 1984, Dr. Bellini established the Bio-chemicals Division of the Institut Armand-Frappier at the Université du Québec, which specializes in research, manufacturing and the commercialization of fine chemicals. He headed up this unit until leaving in 1986 to co-found BioChem Pharma.
Dr. Bellini is also a member of the following Board of Directors: Molson Coors Brewing Company; Montreal Heart Institute Foundation; Italian Chamber of Commerce; the Government of Canada's Science Technology & Innovation Council; and Stem Cell Therapeutics Corp.
He donated $10 M towards a new life sciences building at McGill University.[1] He made a major donation toward a new residence and centre for Alzheimer's sufferers.[2]
For his major contribution in the fields of entrepreneurship, research and economy, Dr. Bellini has received the title of ‘Cavaliere del Lavoro’, the most prestigious honor granted by the Italian government. Over the years, Dr. Bellini has received the following awards.